Similar articles

• Chemotherapy-induced recall of cetuximab and radiation skin reaction.

  Law AB, Junor EJ. Law AB, et al. Clin Oncol (R Coll Radiol). 2009 Feb;21(1):77-8. doi: 10.1016/j.clon.2008.11.001. Epub 2008 Dec 3. Clin Oncol (R Coll Radiol). 2009. PMID: 19056253 No abstract available.
• Severe cutaneous reaction during radiation therapy with concurrent cetuximab.

  Budach W, Bölke E, Homey B. Budach W, et al. N Engl J Med. 2007 Aug 2;357(5):514-5. doi: 10.1056/NEJMc071075. N Engl J Med. 2007. PMID: 17671265 No abstract available.
• High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.

  Giro C, Berger B, Bölke E, Ciernik IF, Duprez F, Locati L, Maillard S, Ozsahin M, Pfeffer R, Robertson AG, Langendijk JA, Budach W. Giro C, et al. Radiother Oncol. 2009 Feb;90(2):166-71. doi: 10.1016/j.radonc.2008.09.007. Epub 2008 Oct 30. Radiother Oncol. 2009. PMID: 18977050
• Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?

  Bernier J, Schneider D. Bernier J, et al. Eur J Cancer. 2007 Jan;43(1):35-45. doi: 10.1016/j.ejca.2006.08.035. Epub 2006 Nov 13. Eur J Cancer. 2007. PMID: 17098420 Review.
• Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?

  Bourhis J, Lefebvre JL, Vermorken JB. Bourhis J, et al. Eur J Cancer. 2010 Jul;46(11):1979-89. doi: 10.1016/j.ejca.2010.05.015. Epub 2010 Jun 17. Eur J Cancer. 2010. PMID: 20561781 Review.